Generic

Obeticholic Acid

Description

Obecol-5, manufactured by Popular Pharmaceuticals Ltd., contains 5 mg of Obeticholic Acid, an FXR agonist used to manage liver conditions.

Benefits

The medication is primarily effective in treating liver diseases such as primary biliary cholangitis (PBC), especially in patients who are unresponsive to other treatments.

Ingredients

The active ingredient in Obecol-5 is Obeticholic Acid.

Uses and Doses

Obecol-5 is prescribed for adults with PBC who do not respond adequately to Ursodeoxycholic Acid (UDCA). The starting dose is usually 5 mg daily, which can be increased based on the patient's response.

Side Effects

Common side effects include pruritus, fatigue, abdominal pain, and discomfort. Other potential side effects are dizziness and constipation.

How to Use

The tablet should be taken orally, with or without food. Timing should be adjusted if taken with bile acid binding resins.

Pregnancy & Lactation

The effects of Obecol-5 during pregnancy and lactation are not well-documented, hence it should be used only if absolutely necessary.

Precautions and Warnings

Patients with advanced liver disease need careful monitoring, and dosage adjustments may be necessary to prevent worsening of the condition.

Safety Information

Store the medication in a cool, dry place away from light and out of reach of children.

Indications

Obecol-5 is indicated for the treatment of PBC as a monotherapy or in combination with UDCA.

Pharmacology

Obeticholic Acid acts by activating the farnesoid X receptor (FXR), which plays a critical role in bile acid synthesis and regulation.

Therapeutic Class

Farnesoid X Receptor Agonists.

Storage Conditions

The tablets should be stored at temperatures ranging from 15°C to 30°C, in a dry place shielded from light.

FAQs

1. Can Obecol-5 be taken with food? - Yes, it can be taken with or without food.
2. What should I do if I experience severe side effects? - Contact your healthcare provider immediately.
3. How should I store Obecol-5? - Store at 15°C to 30°C, away from moisture and light.

Disclaimer

This information is provided for educational purposes and should not replace professional medical advice.

Keywords: Obecol-5, Obeticholic Acid, PBC treatment, liver disease, FXR agonist, liver health, Ursodeoxycholic Acid, pharmaceuticals, liver therapy, chronic liver conditions, medical treatment, liver function, bile acid management, healthcare, medication safety, primary biliary cholangitis, adult medication, liver pharmacology, prescription medicine, hepatology.